Formulation Development of DS003 in Ethylene Vinyl Acetate Vaginal Rings

Matthew Wilson, K Malcolm, Wendy Blanda, Jeremy Nutgall, Anita Garg, Andrew Brimer, P Boyd

Research output: Contribution to conferenceAbstract

Abstract

DS003 is a potent antiretroviral entry inhibitor molecule being developed by the International Partnership for Microbicides (IPM) as a vaginal microbicide candidate. With the ultimate goal of developing a combination microbicide vaginal ring containing DS003 and dapivirine, this study evaluated the potential for incorporation of high loadings of DS003 in ethylene vinyl acetate (EVA) matrix-type rings suitable for testing in macaques.
Original languageEnglish
PagesP07.39
DOIs
Publication statusPublished - 1 Oct 2016
Event2nd HIV Research for Prevention Conference - Chicago, United States
Duration: 17 Oct 201621 Oct 2016

Conference

Conference2nd HIV Research for Prevention Conference
Abbreviated titleHIVR4P
CountryUnited States
CityChicago
Period17/10/1621/10/16

Fingerprint Dive into the research topics of 'Formulation Development of DS003 in Ethylene Vinyl Acetate Vaginal Rings'. Together they form a unique fingerprint.

  • Cite this

    Wilson, M., Malcolm, K., Blanda, W., Nutgall, J., Garg, A., Brimer, A., & Boyd, P. (2016). Formulation Development of DS003 in Ethylene Vinyl Acetate Vaginal Rings. P07.39. Abstract from 2nd HIV Research for Prevention Conference , Chicago, United States. https://doi.org/10.1089/aid.2016.5000.abstracts